Projecting the cost of introducing typhoid conjugate vaccine (TCV) in the national immunization program in Malawi using a standardized costing framework.

ABSTRACT:

Background

There is a substantial typhoid burden in sub-Saharan Africa, and TCV has been introduced in two African countries to date. Decision-makers in Malawi decided to introduce TCV and applied for financial support from Gavi, the Vaccine Alliance in 2020. The current plan is to introduce TCV as part of the national immunization program in late 2022. The introduction will include a nationwide campaign targeting all children aged 9 months to 15 years. Following the campaign, TCV will be provided through routine immunization at 9 months. This study aims to estimate the cost of TCV introduction and recurrent delivery as part of the national immunization program.

Methods

This costing analysis is conducted from the government's perspective and focuses on projecting the increme

SUBMITTER: Debellut F 

PROVIDER: S-EPMC8917043 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature